Eun Ji Kim Selected Research

n-butylamine

11/2020

GeTe-Based Alloy Films Prepared by a Room Temperature Solution Process.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eun Ji Kim Research Topics

Disease

32	Neoplasms (Cancer) 01/2020 - 08/2003
11	Colonic Neoplasms (Colon Cancer) 04/2015 - 07/2002
9	Neoplasm Metastasis (Metastasis) 10/2021 - 12/2009
7	Prostatic Neoplasms (Prostate Cancer) 06/2014 - 01/2006
6	COVID-19 10/2022 - 01/2020
6	Breast Neoplasms (Breast Cancer) 07/2022 - 08/2011
6	Obesity 02/2022 - 08/2011
6	Lung Neoplasms (Lung Cancer) 10/2021 - 06/2016
5	Infections 01/2021 - 01/2019
5	Carcinoma (Carcinomatosis) 04/2017 - 01/2006
4	Inflammation (Inflammations) 01/2022 - 07/2010
4	Carcinogenesis 06/2014 - 07/2002
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 12/2013
3	Body Weight (Weight, Body) 10/2021 - 09/2015
3	Stomach Neoplasms (Stomach Cancer) 01/2014 - 06/2011
2	Stroke (Strokes) 04/2022 - 06/2012
2	Melanoma (Melanoma, Malignant) 03/2022 - 09/2015
2	Hypoxia (Hypoxemia) 10/2021 - 01/2013
2	Phototoxic Dermatitis (Phototoxicity) 10/2021 - 11/2020
2	Fibrosis (Cirrhosis) 12/2020 - 01/2016
2	Wounds and Injuries (Trauma) 01/2020 - 01/2016
2	Hepatocellular Carcinoma (Hepatoma) 02/2018 - 11/2008
2	Hypertension (High Blood Pressure) 01/2018 - 06/2014
2	Cicatrix (Scar) 03/2017 - 01/2016
2	Drug-Related Side Effects and Adverse Reactions 01/2015 - 11/2014
2	Adenocarcinoma 01/2014 - 02/2011
2	Leukemia 12/2011 - 12/2007
1	Rare Diseases (Rare Disease) 12/2022
1	Hemorrhage 04/2022
1	Atrial Fibrillation 04/2022
1	Insulin Resistance 01/2022
1	Reinfection 12/2021

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 10/2021 - 01/2015
5	Conjugated Linoleic AcidsIBA 04/2006 - 07/2002
4	LipidsIBA 12/2020 - 08/2011
4	Keratins (Keratin)IBA 05/2018 - 01/2016
4	Ethanol (Ethyl Alcohol)IBA 02/2018 - 06/2014
4	sphingosine phosphorylcholineIBA 03/2017 - 01/2016
4	Death Domain ReceptorsIBA 06/2011 - 10/2009
3	Phosphotransferases (Kinase)IBA 07/2022 - 01/2005
3	AntioxidantsIBA 02/2022 - 11/2008
3	Biomarkers (Surrogate Marker)IBA 08/2021 - 11/2014
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 11/2011
3	Keratin-8 (Keratin 8)IBA 05/2018 - 03/2016
3	SteroidsIBA 01/2015 - 01/2011
3	Biological ProductsIBA 07/2013 - 08/2010
3	EnzymesIBA 08/2011 - 01/2007
3	3,3'-diindolylmethane (diindolylmethane)IBA 02/2011 - 12/2009
3	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 04/2006 - 07/2002
2	Triglycerides (Triacylglycerol)IBA 12/2022 - 05/2013
2	HDL CholesterolIBA 12/2022 - 05/2013
2	Interferon Type IIBA 10/2022 - 03/2021
2	RNA (Ribonucleic Acid)IBA 10/2021 - 06/2017
2	VimentinIBA 10/2021 - 12/2016
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 08/2021 - 01/2012
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 01/2020
2	tegoprazanIBA 01/2021 - 01/2020
2	AcidsIBA 01/2021 - 01/2020
2	PotassiumIBA 01/2021 - 01/2020
2	Therapeutic UsesIBA 12/2020 - 06/2012
2	oxidized low density lipoproteinIBA 01/2020 - 01/2020
2	LDL CholesterolIBA 01/2020 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2020
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 12/2009
2	Complement System Proteins (Complement)IBA 01/2020 - 08/2011
2	Cell Adhesion MoleculesIBA 01/2020 - 08/2011
2	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2019
2	oligochitosanIBA 01/2019 - 05/2018
2	Cytochromes c (Cytochrome c)IBA 04/2017 - 10/2006
2	Small Interfering RNA (siRNA)IBA 06/2016 - 09/2015
2	urushiolIBA 07/2014 - 05/2013
2	HexanesIBA 01/2012 - 12/2008
2	dehydrocostus lactoneIBA 01/2012 - 12/2008
2	benzyl isothiocyanateIBA 01/2012 - 11/2011
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2011 - 02/2011
2	CytokinesIBA 08/2011 - 12/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2011 - 08/2003
2	AndrogensIBA 10/2009 - 12/2008
2	isoliquiritigenin (GU 17)IBA 10/2006 - 01/2006
2	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2005 - 08/2003
1	evinacumabIBA 12/2022
1	ISIS 304801IBA 12/2022
1	Lipoproteins (Lipoprotein)IBA 12/2022
1	AnticoagulantsIBA 04/2022
1	N(4)-oleylcytosine arabinosideIBA 04/2022
1	Warfarin (Coumadin)FDA LinkGeneric 04/2022
1	interferon tauIBA 03/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2022
1	CeramidesIBA 01/2022
1	SphingolipidsIBA 01/2022
1	Neutralizing AntibodiesIBA 12/2021
1	Malate Dehydrogenase (Dehydrogenase, Malate)IBA 10/2021
1	Cadherins (E-Cadherin)IBA 10/2021
1	palmidrolIBA 10/2021
1	Diclofenac (SR 38)FDA LinkGeneric 10/2021
1	Dacarbazine (DIC)FDA LinkGeneric 10/2021

Therapy/Procedure

4	Therapeutics 12/2022 - 01/2019
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2018 - 01/2012
2	Oral Administration 11/2011 - 12/2009